Delaware
|
|
001-34703
|
|
20-0028718
|
||
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
||
|
|
|
||||
6120 Windward Parkway
Suite 290
Alpharetta, Georgia
|
|
30005
|
||||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Not Applicable
|
(Former name or former address if changed since last report.)
|
Name and Title of Officer
|
2018 Salary
|
2019 Salary
(1)
|
RSUs
(2)
|
Stock Options
(3)
|
|
|
|
|
|
Richard S. Eiswirth, Jr.
President and Chief Executive Officer |
$495,000
|
$525,000
|
201,100
|
500,000
|
J. Philip Jones
Chief Financial Officer |
$233,465
|
$285,000
|
79,400
|
250,000
|
Philip Ashman, Ph. D.
Chief Operating Officer and Senior
Vice President Commercial
Operations Europe
|
£250,000
|
£260,000
|
92,300
|
200,000
|
(1)
|
2019 salaries are effective as of January 1, 2019.
|
(2)
|
At management’s request, the Compensation Committee again granted restricted stock units (“RSUs”) in lieu of a cash bonus plan to conserve the Company’s liquidity, continuing the practice it began in January 2017 and followed in January 2018. The RSUs will vest as follows:
|
Name of Officer
|
Vesting Date
|
Number of
Shares Vested |
|
|
|
Philip Ashman, Ph. D.
|
2/28/2020
|
46,150
|
J. Philip Jones
|
2/28/2020
|
39,700
|
Philip Ashman, Ph. D.
|
3/2/2020
|
46,150
|
J. Philip Jones
|
3/2/2020
|
39,700
|
Richard S. Eiswirth, Jr.
|
3/5/2020
|
100,550
|
Richard S. Eiswirth, Jr.
|
3/6/2020
|
100,550
|
(3)
|
The exercise price for each option is $0.86, the closing price of the Company’s common stock on the Nasdaq Global Market on January 23, 2019. Each option vests in 1/48th increments monthly over four years. Options are incentive stock options to the maximum extent allowed under the Alimera Sciences, Inc. 2010 Equity Incentive Plan.
|
|
ALIMERA SCIENCES, INC.
|
|
|
|
|
Dated: January 25, 2019
|
By:
|
/s/ J. Philip Jones
|
|
Name:
|
J. Philip Jones
|
|
Title:
|
Chief Financial Officer
|